# AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results
Canonical URL: https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-earnings-release-date-conference-call-and-webca-d61b9662
Ticker: AIRS
Company: Airsculpt Technologies
Source: Airsculpt Technologies
Published: 2026-05-01 10:45 EST
## Summary

Company to Participate in Upcoming Investor Conferences May 01, 2026 06:45 ET | Source: Airsculpt Technologies, Inc. ...

## Article Body
Company to Participate in Upcoming Investor Conferences

May 01, 2026 06:45 ET | Source: Airsculpt Technologies, Inc.

MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13760143 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Technologies website at https://investors.airsculpt.com . A replay of the webcast will be available for approximately 90 days.

The Company also announced its participation in upcoming investor conferences.

On May 18, 2026, the Company will participate in the Wolfe Research Global Consumer Growth Conference being held virtually on May 18, 2026. Management will host a fireside chat presentation at 1:30 p.m. Eastern Time and hold virtual investor meetings throughout the day.

On May 19, 2026, the Company will participate in the 16 th Annual LD Micro Invitational being held at the Luxe Sunset Blvd Hotel in Los Angeles on May 19, 2026. Management will host a presentation at 12:30 p.m. Pacific Time and hold investor meetings throughout the day.

The fireside chat presentations at both conferences will be available live and for replay on the Investor Relations page on the company's website at https://investors.elitebodysculpture.com .

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

Investor Contact:

Allison Malkin Partner, ICR Inc. AirSculpt@icrinc.com
## Recent Company News
- 2026-05-27 20:05 EST — [AirSculpt Technologies Announces Participation in Upcoming Investor Conferences](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-participation-in-upcoming-investor-conferences-2cfd961d) — Source: Airsculpt Technologies
- 2026-05-08 10:30 EST — [AirSculpt Technologies Reports First Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-reports-first-quarter-fiscal-2026-results-64ae47f1) — Source: Airsculpt Technologies
- 2026-05-01 10:45 EST — [AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-earnings-release-date-conference-call-and-webca-d61b9662) — Source: Airsculpt Technologies
- 2026-04-06 10:30 EST — [CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results](https://biopharmsignal.com/news/AIRS/correction-airsculpt-technologies-reports-fourth-quarter-and-full-year-fiscal-20-805a94bd) — Source: Airsculpt Technologies
- 2026-04-02 10:30 EST — [AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-reports-fourth-quarter-and-full-year-fiscal-2025-results-7310ddce) — Source: Airsculpt Technologies
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)